Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 1
1991 4
1992 1
1993 5
1994 3
1995 3
1996 3
1997 2
1998 3
1999 1
2000 3
2001 2
2002 3
2003 6
2004 3
2005 2
2006 3
2007 6
2008 6
2009 4
2010 2
2011 6
2012 6
2013 13
2014 11
2015 8
2016 10
2017 11
2018 7
2019 3
2020 5
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Results by year
Filters applied: . Clear all
Page 1
Metabolic reprogramming in clear cell renal cell carcinoma.
Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH. Wettersten HI, et al. Among authors: weiss rh. Nat Rev Nephrol. 2017 Jul;13(7):410-419. doi: 10.1038/nrneph.2017.59. Epub 2017 May 8. Nat Rev Nephrol. 2017. PMID: 28480903 Review.
Biomarkers in IgA nephropathy.
Hwang VJ, Ulu A, van Hoorebeke J, Weiss RH. Hwang VJ, et al. Among authors: weiss rh. Biomark Med. 2014;8(10):1263-77. doi: 10.2217/bmm.14.92. Biomark Med. 2014. PMID: 25525986 Free article. Review.
Rho GTPase effectors and NAD metabolism in cancer immune suppression.
Chaker M, Minden A, Chen S, Weiss RH, Chini EN, Mahipal A, Azmi AS. Chaker M, et al. Among authors: weiss rh. Expert Opin Ther Targets. 2018 Jan;22(1):9-17. doi: 10.1080/14728222.2018.1413091. Epub 2017 Dec 10. Expert Opin Ther Targets. 2018. PMID: 29207896 Free PMC article. Review.
New opportunities from the cancer metabolome.
Aboud OA, Weiss RH. Aboud OA, et al. Among authors: weiss rh. Clin Chem. 2013 Jan;59(1):138-46. doi: 10.1373/clinchem.2012.184598. Epub 2012 Nov 13. Clin Chem. 2013. PMID: 23150057 Review.
Translating L-2-HG to kidney cancer at the bench and bedside.
Aboud OA, Weiss RH. Aboud OA, et al. Among authors: weiss rh. Ann Transl Med. 2018 Dec;6(Suppl 2):S103. doi: 10.21037/atm.2018.11.41. Ann Transl Med. 2018. PMID: 30740424 Free PMC article. No abstract available.
Metabolomics in the study of kidney diseases.
Weiss RH, Kim K. Weiss RH, et al. Nat Rev Nephrol. 2011 Oct 25;8(1):22-33. doi: 10.1038/nrneph.2011.152. Nat Rev Nephrol. 2011. PMID: 22025087 Review.
Targeting the PI3K-Akt pathway in kidney cancer.
Park JY, Lin PY, Weiss RH. Park JY, et al. Among authors: weiss rh. Expert Rev Anticancer Ther. 2007 Jun;7(6):863-70. doi: 10.1586/14737140.7.6.863. Expert Rev Anticancer Ther. 2007. PMID: 17555396 Review.
136 results